› 6ozk

X-ray diffraction
2.1Å resolution

Crystal structure of Mus musculus (Mm) Endonuclease V in complex with a 23mer RNA oligo containing an inosine after 68h soak in Ca2+

Released:
DOI: 10.2210/pdb6ozk/pdb
PDB entry 6ozk coloured by chain, front view.
PDB entry 6ozk coloured by chain, side view.
PDB entry 6ozk coloured by chain, top view.
Source organisms:
Primary publication:
Evolution of Inosine-Specific Endonuclease V from Bacterial DNase to Eukaryotic RNase.
Wu J, Samara NL, Kuraoka I, Yang W
Mol Cell 76 44-56.e3 (2019)
PMID: 31444105

Function and Biology Details

Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domain:

Structure analysis Details

Assembly composition:
hetero tetramer (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-113228 (preferred)
Entry contents:
1 distinct polypeptide molecule
1 distinct DNA/RNA hybrid molecule
Macromolecules (2 distinct):
Endonuclease V Chains: A, B
Molecule details ›
Chains: A, B
Length: 246 amino acids
Theoretical weight: 27.31 KDa
Source organism: Mus musculus
Expression system: Escherichia coli
UniProt:
  • Canonical: Q8C9A2 (Residues: 6-250; Coverage: 73%)
Gene name: Endov
Sequence domains: Endonuclease V
DNA/RNA (5'-R(P*CP*GP*GP*UP*AP*AP*CP*CP*C)-D(P*I)-R(P*AP*UP*AP*UP*GP*CP*AP*UP*GP*CP*AP*UP*U)-3') Chains: C, D
Molecule details ›
Chains: C, D
Length: 23 nucleotides
Theoretical weight: 7.29 KDa
Source organism: synthetic construct
Expression system: Not provided

Ligands and Environments

5 bound ligands:
Ligand CA 4 x CA
Ligand GOL 5 x GOL
Ligand EDO 1 x EDO
Ligand TLA 3 x TLA
Ligand PGE 2 x PGE
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: APS BEAMLINE 22-BM
Spacegroup: P212121
Unit cell:
a: 71.823Å b: 73.012Å c: 155.229Å
α: 90° β: 90° γ: 90°
R-values:
R R work R free
0.179 0.177 0.214
Expression systems:
  • Escherichia coli
  • Not provided

Quick links

Citations

6 review citations

Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.
Ye et al. (2021)
5 more